Quetiapine Xr : Affected Lots May Exceed The Established Acceptable Intake Limit For N-nitroso-desalkyl-quetiapine (nnap)
Quetiapine XR tablets from certain batches may contain higher-than-acceptable levels of a nitrosamine impurity called N-nitroso-desalkyl-quetiapine (NNAP). This is a quality issue with the medication. The recall affects Quetiapine XR distributed across Canada.
- Product
- QUETIAPINE XR
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-01-07
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/9ed23a05-bfe7-47ff-a59c-c1b918809627